J-Pharma Co., Ltd. (TSE: 520A)
Health Care · Biotechnology · JP
¥336.00
+0.30% today · -52.0% 1Y
J-Pharma Co., Ltd. (TSE: 520A) operates in the Biotechnology industry within the Health Care sector. The company is valued at $38.10M and employs 16 people.
Over the last twelve months the share price has lost 52.0%, trading between 260.00 and 809.00.
Tweenvest scores J-Pharma Co., Ltd. across four factors: quality 44/100, value 100/100. Its strongest factor is value.
520A price history
Key figures
- Market cap
- $38.10M
- Revenue (TTM)
- —
- P/E
- -2.33
- EPS
- -195.08
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ¥809.00
- 52-week low
- ¥260.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.06M
- Employees
- 16
- Next earnings
- —
About J-Pharma Co., Ltd.
J-Pharma Co., Ltd. is engaged in drug discovery and development, focusing on amino acid transporters as drug targets. The company researches and develops drugs targeting solute carrier (SLC) transporters, with emphasis on the LAT1 amino acid transporter. It is developing several compounds for various medical indications, including JPH034 for central nervous system demyelinating diseases and multiple sclerosis. The company conducts functional and structural analysis of selected SLC transporters to support drug discovery, collaborates with academic institutions, and participates in joint research for new pharmaceutical development. It is preparing for clinical trials and global distribution of its drug candidates. The company was founded in 2005 and is based in Yokohama, Japan.
- ISIN
- JP3387030004
- Founded
- 2005
- Listed since
- Mar 25, 2026
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Psomagen, Inc.KOSDAQ: A950200 | $38.71M | ₩2,690.00 | +0.37% |
| Biomea Fusion, Inc.NasdaqGS: BMEA | $38.52M | $0.53 | +8.61% |
| GENINUS Inc.KOSDAQ: A389030 | $38.50M | ₩1,305.00 | +2.11% |
| TMS Co., Ltd.TSE: 4891 | $38.42M | ¥134.00 | -2.90% |
| OSE Immunotherapeutics SAENXTPA: OSE | $37.63M | €1.46 | -10.60% |
| Isofol Medical AB (publ)OM: ISOFOL | $37.23M | Skr1.16 | -15.90% |
| NeoCore Technology Co., Ltd.TPEX: 4131 | $37.01M | NT$30.55 | -1.29% |
| Elutia Inc.NasdaqCM: ELUT | $36.32M | $0.82 | -6.69% |